Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
Review of Chinese Pharma Deals, R&D and Regulatory Developments in 2017
The annual review summarize the important events, including M&A,JV licensing & R&D partnership deals, new drug R&D projects and new regulations, recorded ... (2/7/2018)
   
Why China Will Capitalize on Groundbreaking Healthcare Solutions Before The West (2/13/2018)
How Tencent's Medical Ecosystem Is Shaping the Future of China's Healthcare (2/13/2018)
GSK's Digital Strategies for Reaching New Buyers in China (2/13/2018)
The Chinese Pharmaceutical Industry: Winners and Losers 2017 (2/12/2018)
Review of Chinese Pharma Deals, R&D and Regulatory Developments in 2017 (2/7/2018)
Shanghai AIC Penalizes U.S.-China Joint Venture for Providing Overseas Travel to Hospital Official to Attend European Medical Conference (2/5/2018)
This Is Why Chinese Companies Are Suddenly Targeting Australian Healthcare Businesses (2/2/2018)
Light at the End of Tunnel in the Supposedly Hopeful Year of the "Earth Dog" (1/31/2018)
Why Most Small Players May Not Survive China's Pharmaceutical Industry Consolidation (1/30/2018)
Compliance in China: Key Considerations (1/30/2018)
Made in China: New and Potentially Lifesaving Drugs (1/19/2018)
Update on US Investigation of China's IP Practices (1/19/2018)
Fosun-Backed Shanghai Henlius Biotech Eyes IPOs on Both Mainland and HK Stock Markets (1/19/2018)
Hua Medicine Mulls Hong Kong IPO as Diabetes Drug Enters Crucial Clinical Trial Phase (1/18/2018)
New Opportunities in Emerging Markets (1/18/2018)
Recent Executive Moves  (2/15/2018)
British Government Announces Healthcare ...  (2/14/2018) (free)
China's R&D Spending at Record High ...  (2/14/2018)
CFDA Releases List of Reference Formulat...  (2/14/2018)
China Reviews Achievements of the BMI Sy...  (2/14/2018)
MOLOGEN Signs Deal with ONCOLOGIE for Le...  (2/13/2018)
UK Investigators Ask for New Info from G...  (2/13/2018)
GNC Announces $300M Partnership with Har...  (2/13/2018)
India Pharma Companies See Growing Oppor...  (2/13/2018)
GC Pharma and Lee's Pharm Enter into Chi...  (2/13/2018)
MSD Files NDA for Anticancer Keytruda in...  (2/13/2018)
CFDA Seeks Comments on Draft Document fo...  (2/13/2018)
BeiGene Presents Preliminary Phase 1 Dat...  (2/13/2018)
Chi-Med Enrolls 527 Patients in Pivotal ...  (2/13/2018) (free)
CFDA Publishes Its 2018 Legislation Plan...  (2/12/2018)
Global Contract Pharmaceutical Manufacturing Market to R...
White House Task Force Echoes Pharma Proposals
Pharma Industry Reputation Rebounds Somewhat in 2016
Fresenius Steps Up Pharma M&A with Akorn, Merck KGaA...
Global Pharmerging Market to Grow at a CAGR of 12.88% in...
South Korea's Pharmaceutical Export to China Jumped Nearly 400%...
IQVIA: Chinese Hospital Drug Sales Up 6.2% in Q3/2017
IQVIA: Chinese Retail Pharmacy Sales Up 2. 6% in MAT Q3/2017
Nicholas Hall Reports 8% Growth of OTC Gastrointestinal Market ...
Fear of Substandard Medicines Lead to Expanding Opportunities f...
MOLOGEN Signs Deal with ONCOLOGIE for Lead Compound Lefitoli...
GNC Announces $300M Partnership with Harbin Pharma
India Pharma Companies See Growing Opportunities in China fo...
GC Pharma and Lee's Pharm Enter into China Licensing Agreeme...
MSD Files NDA for Anticancer Keytruda in China
CFDA Releases List of Reference Formulations for Generic...
CFDA Seeks Comments on Draft Document for Matters Relate...
CFDA Publishes Its 2018 Legislation Plan
CDE Solicits Comments on the General Requirements on Bat...
CFDA Releases List of Reference Formulations for Generic...
UK Investigators Ask for New Info from GSK Relating to Its C...
Shanghai AIC Terminates Antimonopoly Investigation of the Ci...
NHFPC Solicits Feedbacks on Proposed Measure to Eliminate Pr...
USTR's 2017 Report for China's WTO Compliance Highlight IP I...
USDOC Points Out "Shortcomings" in China's Pharma IP Arena
India to Blacklist Eight Chinese Pharma Companies for Qu...
EMA Bans Amoxicillin API from Changsheng Pharma after Id...
Fast Rising Price of Chinese APIs Puts Pressure on Botto...
China to Restrict Production of API Producers in 28 Citi...
Asymchem Labs Announces 2nd TGA Inspection of Its Jilin ...
China's R&D Spending at Record High in 2017
BeiGene Presents Preliminary Phase 1 Data on Tislelizuma...
Chi-Med Enrolls 527 Patients in Pivotal Phase III FALUCA...
BeiGene Announces Commercial Availability of VIDAZA (Aza...
BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Anti...
British Government Announces Healthcare Deals with China...
China Reviews Achievements of the BMI System and Medical...
More Provincial Governments Liberalize Non-essential Dru...
Four Central Government Agencies Issue Joint Notice for ...
Chinese People Losing Their Hair Earlier Than Ever Befor...
Recent Executive Moves
Recent Executive Moves
CFDA Vice Minister SUN Xianze to Leave the Agency
Recent Executive Moves
Recent Executive Moves
AmCham: U.S. Cos in China Increasingly Upbeat on Economy...
Upcoming Event: Orthopedics 2018
Upcoming Event: 7th International Chronic Obstructive Pu...
CASS: Chinese Economy May See 25% Drop without Populatio...
Upcoming Event: Alzheimer 2018
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links